I. Process indicators
|
Average
| | |
A. Timely detection of T2D complications and comorbidity in the last year
| | | | |
1. At least one measurement of HbA1c
|
8.7
|
7.8
|
Accepted
|
Programmable
|
2. Comprehensive foot evaluation
|
8.7
|
8.2
|
Accepted
|
Programmable
|
3. Referral to the ophthalmologist
|
8.3
|
7.7
|
Accepted
|
Programmable
|
4. Screening for microalbuminuria through the ratio albumin/creatinine
|
8.5
|
5.7
|
Discarded
| |
5. Measurement of creatinine and rate of glomerular filtration
|
8.7
|
5.3
|
Discarded
| |
6. Screening for dyslipidemia by measuring total cholesterol in patients without previous diagnosis of dyslipidemia
|
8.5
|
7.8
|
Accepted
|
Programmable
|
B. Non pharmacological treatment in the last year
| | | | |
7. Smoking cessation counseling for current smokers
|
8.2
|
8
|
Accepted
|
Not Programmable
|
8. Advise to moderate alcohol consumption
|
6.0
|
5.8
|
Discarded
| |
9. Nutritional counseling provided by the nutrition service
|
7.8
|
7.8
|
Accepted
|
Programmable
|
10. Advise to practice aerobic physical exercise of moderate intensity, at least 150 minutes per week, unless contraindicated
|
8.2
|
8.0
|
Accepted
|
Not Programmable
|
11. Registration of adherence to dietary recommendations
|
8.5
|
7.0
|
Accepted
|
Not Programmable
|
12. Registration of adherence to aerobic physical exercise
|
8.5
|
7.0
|
Accepted
|
Not Programmable
|
C. Pharmacological treatment in the last three visits
| | | | |
13. Overweight/obese (BMI ≥ 25 kg/m2) patients who received metformin, unless contraindicated*
|
8.7
|
8.5
|
Accepted
|
Programmable
|
14. Patients with HbA1c ≥ 8, or with an average fasting blood glucose of ≥140 mg/dl in the last 3 months, who had registered: a) recommendations to modify their diet and physical exercise, b) referral to a social work group; c) modification in their scheme of treatment.
|
8.7
|
6.3
|
Discarded
| |
15. Patients with HbA1c ≥ 8, or with an average fasting blood glucose of ≥140 mg/dl in the last 3 months, who had registered adherence to the pharmacological treatment.
|
8.5
|
6.8
|
Discarded
| |
16. Patients with hypertension receiving inhibitors of angiotensin converting enzyme or angiotensin-receptor blocker, otherwise contraindicated**
|
8.5
|
8.5
|
Accepted
|
Programmable
|
17. Patients > 40 years of age with one or more of the following risk factors: smoking, hypertension, dyslipidemia, receiving 75-150 mg/day of acetylsalicylic acid, unless contraindicated***
|
8.5
|
8.2
|
Accepted
|
Programmable
|
18. Patient with total cholesterol >200 mg/dl and were prescribed statins, unless contraindicated****
|
8.2
|
8.3
|
Accepted
|
Programmable
|
II. Health outcomes indicators
| | | | |
19. HbA1c <7% or fasting glucose ≤130 mg/dl in the last 3 measurements
|
8. 7
|
8.3
|
Accepted
|
Programmable
|
20. Total cholesterol levels < 200 mg/dl in the last measurement
|
8. 7
|
8.2
|
Accepted
|
Programmable
|
21. Blood pressure <130/80 mmHg in the last 3 measurements
|
8. 7
|
8.5
|
Accepted
|
Programmable
|
22. Overweight/obese (BMI ≥ 25 kg/m2) patients who lost ≥5% body weight in the last year
|
8.0
|
7. 7
|
Accepted
|
Programmable
|
Composed indicator of health outcomes
| | | | |
23. Patients with HbA1c <7%, or fasting glucose ≤130 mg/dl, total cholesterol levels < 200 mg/dl and blood pressure <130/80 mmHg in the last 3 measurements
|
8.5
|
7.5
|
Accepted
|
Programmable
|